Raphael Pharmaceutical Inc. (RAPH)
Market Closed
16 Oct, 08:00 PM
OTC PINK OTC PINK Primary $
1. 51
+0.11
+7.8571%
$
28.25M Market Cap
- P/E Ratio
- Div Yield
100 Volume
0 Eps
$ 1.4
Previous Close Want to track RAPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Raphael Pharmaceutical Inc. (RAPH) Statistics
Valuation metrics
Market Cap 28.25M
Enterprise value 30.51M
Trailing P/E (ttm) -30.69
Forward P/E -
PEG ratio -0.64
Price/Sales (ttm) -
Price/Book (mrq) -16.16
Enterprise Value/Revenue -
Enterprise Value/EBITDA -32.95
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 12
Average volume (90 days) 9
Price summary
52-Week low 0.4
52-Week high 1.51
Beta -
50-Day moving average 1.4
200-Day moving average 1.4
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -140%
Return on equity 0.63%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.05
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -0.02
Current ratio (mrq) 0%
Book value per share (mrq) -0.09
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
